Headline News about Lexicon Pharmaceutcl
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
5 Analysts Have This To Say About Lexicon Pharmaceuticals
August 02, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/08/02/xrdDAFqe777JJc2-j3049335502123804312-t23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/08/02/Tel-Aviv--Israel---March-30--2016-Intel-_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/17/movers.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Lexicon Pharmaceuticals: Q4 Earnings Insights
March 11, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/17/Movers.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/01/Stock-cytokinetics-office-01-company.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/04/22/Image22_1.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Lexicon Pharmaceuticals's Earnings: A Preview
November 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/03/27/image30_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/03/27/cintas_-_logo_copy.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/03/12/image31_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/03/11/image44.jpg?width=1200&height=800&fit=crop)
Dow Turns Higher; GDS Holdings Shares Climb
March 11, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2024/03/11/crude_oil_4-_logo.jpg?width=1200&height=800&fit=crop)
Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump
March 11, 2024
Via Benzinga
Topics
Stocks
![](https://cdn.benzinga.com/files/images/story/2024/02/15/image39.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/03/11/image16_0.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/762960/rocket-coins-calculator-financial-metrics-to-moon-crypto-invest-getty.jpg)
![](https://g.foolcdn.com/editorial/images/762125/lucid-air.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/20/fluor_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/759728/one-hundred-dollar-bill-cash-money-invest-2024-calculator-getty.jpg)
![](https://g.foolcdn.com/editorial/images/759276/ascending-bar-chart-line-invest-financial-newspaper-stock-market-quote-rally-bull-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/14/image29.jpeg?width=1200&height=800&fit=crop)
Insiders Buying Blend Labs And 3 Other Stocks Under $2
November 14, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/11/01/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/01/amd_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/17/servisfirst_bancshares_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/13/image15.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/10/image13.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/750455/pharmacy-pharmacist-drug-medicine-prescription-2.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.